From this perspective, endogenous tau-linked homeostatic adaptations could in fact be triggered by the initial Aβ-mediated hyperactivity in AD but, when sustained, could become detrimental in the hypoactive phase linked to pathogenic tau. The gene discussed is MAPT; the disease is Alzheimer disease.